Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma

doi:10.3748/wjg.v12.i23.3707

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3611)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-2) series.

Item

Count

PDF

344

HTML

2919

Figures (1-7)

180

Tables (1-2)

168

Sum=3611

Jun 21, 2006 (publication date) through Jul 20, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jun 21, 2006; 12(23): 3707-3715
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3707

Full Size Figure Download Figure

Figure 3 Comparison of Kaplan-Meier curves showing the survival probabilities of the four subgroups: TACE-PEI combination, PEI alone, secondary PEI after TACE, secondary PEI after best supportive care. The highest survival probabilities can be expected in the combination treatment group initially stratified to TACE followed by repeated single session PEI.

Citation: Dettmer A, Kirchhoff TD, Gebel M, Zender L, Malek NP, Panning B, Chavan A, Rosenthal H, Kubicka S, Krusche S, Merkesdal S, Galanski M, Manns MP, Bleck JS. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma. World J Gastroenterol 2006; 12(23): 3707-3715
URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3707.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i23.3707